Akynzeo for post-operative nausea and vomiting after bariatric surgery.

Phase 4

Recruiting

• Conditions: morbid obesity; Post-operative nausea and vomitting; Anaesthesiology - Anaesthetics; Diet and Nutrition - Obesity; Surgery - Other surgery

• Registration Number: ACTRN12620000455965
• Lead Sponsor: St Vincent's Hospital Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-08
• Last Update Posted: 27 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Patients eligible for participation in this trial include all adults aged 18 years and above and below the age of 70 years undergoing elective laparoscopic bariatric surgery.

Exclusion Criteria

Patients will be excluded if they have a known allergy to any antiemetic to be administered as part of the trial (netupitant, palonosetron or standard treatment), significant psychiatric disease, renal impairment or those taking any medications with known interaction with the study drugs (amiodarone, carbamazepine, colchicine, etc.).

Study & Design

• Study Type: Interventional
• Study Design: Not specified